We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program

News   Aug 06, 2015

 
MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program
 
 
 

RELATED ARTICLES

Immunotherapy Opportunities Lie in Glioma Molecular Landscape

News

A slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which gives the immune system a boost in fighting cancer.

READ MORE

Antibiotics Generated from Wasp Venom

News

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

READ MORE

High-throughput Platform Enables Activity Mapping of Emerging Cancer Drug Targets

News

A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for cancer treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE